Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumour Response,”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT02943473
What this trial is testing

Study on the Effect of Ibrutinib on High Risk Smoldering Multiple Myeloma Patients

Who this might be right for
High Risk Smoldering Multiple Myeloma
Icahn School of Medicine at Mount Sinai 9
Not applicableUnknownNCT01330186
What this trial is testing

Predictive Value of FMISO-PET, FDG-PET-CT, DWI-MRI and DCE-MRI Scans for Patients With Anal Cancer Receiving Radiotherapy +/- Chemotherapy

Who this might be right for
Anal Cancer
Copenhagen University Hospital at Herlev 50
Testing effectiveness (Phase 2)Ended earlyNCT01625741
What this trial is testing

Phase II Study of High-Dose Rituximab in High-Risk Chronic Lymphocytic Leukemia Patients in Suboptimal Response After Induction Immunochemotherapy

Who this might be right for
Chronic Lymphocytic Leukemia
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 6
Not applicableStudy completedNCT02366286
What this trial is testing

Hepatitis B and Hepatitis C as Risk Factors for Hepatocellular Carcinoma in African and Asian Immigrants

Who this might be right for
Hepatitis BHepatitis CCarcinoma, Hepatocellular
Mayo Clinic 892
Large-scale testing (Phase 3)Study completedNCT00468546
What this trial is testing

Evaluate the Safety and Efficacy of MabThera (Rituximab) in Combination With Methotrexate (MTX) in Participants With Active Rheumatoid Arthritis Who Failed on Anti-Tumor Necrosis Factor Alpha Therapy

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 520
Not applicableStudy completedNCT05931042
What this trial is testing

Neoadjuvant Therapy With Trastuzumab and Chemotherapy and the Resultant Pathologic Complete Response Observed in HER2 Positive Breast Cancer;a Systematic Review

Who this might be right for
HER2+ Breast Cancer
Rawalpindi Medical College 1,209
Testing effectiveness (Phase 2)Looking for participantsNCT06444269
What this trial is testing

Precision Medicine in Action: Phase II Trial of Response Adaptive Ablative Pre-operative SPBI (RAPS) and Non-operative Sentinel Lymph Node Biopsy in Patients With Early-stage ER+ Breast Cancer: RAPS Trial

Who this might be right for
Breast Cancer
University of Texas Southwestern Medical Center 53
Not applicableStudy completedNCT02488369
What this trial is testing

Diagnostic Qualities of the Positron Emission Tomography Coupled to the Scanner (PET / CT) in the Assessment of Response to Non-Hodgkin's Lymphoma Therapy in Children and Adolescents

Who this might be right for
Non-Hodgkin Lymphoma
Gustave Roussy, Cancer Campus, Grand Paris 230
Not applicableUnknownNCT06280872
What this trial is testing

Physiologically Based Cord Clamping To Improve Neonatal Outcomes In Moderate And Late Preterm Newborns

Who this might be right for
Premature BirthRespiratory Distress Syndrome in Premature InfantSepsis+3 more
Queen Fabiola Children's University Hospital 180
Not applicableEnded earlyNCT03412630
What this trial is testing

Perfusion CT in Predicting Outcomes in Ovarian, Fallopian, or Peritoneal Cancer With Bevacizumab

Who this might be right for
Recurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal Carcinoma
ECOG-ACRIN Cancer Research Group 1
Testing effectiveness (Phase 2)Study completedNCT03829007
What this trial is testing

PD-L1 ImagiNg to prediCt Durvalumab Treatment Response in HNSCC

Who this might be right for
Head and Neck Cancer
Radboud University Medical Center 33
Not applicableNot Yet RecruitingNCT07163507
What this trial is testing

Immune Response to Immunotherapy in Lung Cancer: Study of Sputum and Blood Samples

Who this might be right for
Lung Cancer (NSCLC)Lung Cancer (Non-Small Cell)
University Hospital, Tours 50
Not applicableLooking for participantsNCT05772481
What this trial is testing

Interest of PET-MRI in the Evaluation of the Response After Neoadjuvant Treatment of Locally Advanced Rectal Adenocarcinoma

Who this might be right for
Rectal Cancer
Centre Paul Strauss 50
Very early researchStudy completedNCT03972228
What this trial is testing

Microdevice for Evaluating Drug Response in Site in Lung Lesions

Who this might be right for
Lung TumorLung Cancer
Oliver Jonas 5
Not applicableLooking for participantsNCT06752512
What this trial is testing

Remote Temperature Monitoring of Patients At Risk for Developing Fever

Who this might be right for
FeverCancerRemote Patient Monitoring
AION Biosystems 150
Not applicableNot Yet RecruitingNCT07404228
What this trial is testing

Multidimensional Study Designed to Develop a Methodological Framework Based on MRI Data to Predict Pathological Complete Response (pCR) in Patients With Locally Advanced Rectal Cancer After Neoadjuvant Treatment

Who this might be right for
Rectal CancerChemoradiotherapyMri
Institut du Cancer de Montpellier - Val d'Aurelle 115
Not applicableEnded earlyNCT06181201
What this trial is testing

Association Between the Composition of the Intestinal Microbiota and Tumor Response in Locally Advanced Rectal Cancer

Who this might be right for
Cancer of Rectum
Centre Oscar Lambret 2
Not applicableLooking for participantsNCT05444712
What this trial is testing

Transplantation After Complete Response In Patients With T-cell Lymphoma

Who this might be right for
Peripheral T Cell Lymphoma
Hospices Civils de Lyon 204
Very early researchWithdrawnNCT05054400
What this trial is testing

Study of Laser Interstitial Thermal Therapy (LITT) Treatment Response Assessment With Fluciclovine PET MR

Who this might be right for
Brain MetastasesCancerGliomas+1 more
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT05265988
What this trial is testing

Multiparametric Assessment of Bone Response in mCRPC Patients Treated With Cabozantinib

Who this might be right for
Carcinoma Prostate
Alfredo Berruti 32
Next Page